Latest Revenue Streaming News

Charter Hall Group has raised its FY26 operating earnings per security guidance by 5.5%, reflecting robust momentum in property investments and funds management. The upgrade signals growing investor confidence and increased transaction volumes across its platforms.

Spacetalk Ltd reveals a successful pivot to a software-led, hardware-enabled model, reporting 12% revenue growth and expanding into 15 international markets. The company targets $20–25 million in recurring revenue for 2026, underpinned by new product launches and strategic telco partnerships.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

Tinybeans Group launches a partially underwritten entitlement offer to fund the integration of its recent acquisition Qeepsake, aiming to boost product innovation and subscriber growth.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Stakk Limited has secured a strategic multi-year partnership with Stride Bank, a 110-year-old U.S. institution, further accelerating its annualised recurring revenue and broadening its footprint across American financial sectors.

Worley Limited reported solid financial results for FY2025, highlighted by disciplined capital management including a $269 million share buy-back and a strong focus on sustainability. The company outlined strategic priorities and anticipates moderate growth in FY2026 with a new growth strategy to be revealed next year.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

I Synergy Group’s subsidiary has inked four separate 12-month leases for its AI computing hardware and software, marking a strategic push into recurring revenue streams.

Conrad Asia Energy Ltd has had its trading suspension lifted following the completion of a significant farm down of 75% of its Duyung Production Sharing Contract. This move marks a pivotal moment for the company’s asset portfolio and market presence.